Table 3.
Characteristic | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
P-value | OR | 95% CI | P-value | OR | 95% CI | |
Year of diagnosis | 0.903 | |||||
2004–2007 | 1 | |||||
2009–2011 | 0.838 | 0.952 | 0.592–1.530 | |||
2012–2015 | 0.651 | 0.875 | 0.490–1.562 | |||
Gender | ||||||
Male | 1 | 1 | ||||
Female | 0.056 | 0.491 | 0.237–1.018 | 0.148 | 0.574 | 0.270–1.219 |
Age groups (years) | 0.554 | |||||
≤50 | 1 | |||||
51–60 | 0.617 | 1.223 | 0.556–2.694 | |||
61–70 | 0.657 | 1.188 | 0.555–2.546 | |||
≥71 | 0.215 | 1.715 | 0.732–4.021 | |||
Race | ||||||
White | 1 | |||||
Black and others | 0.177 | 0.537 | 0.218–1.325 | |||
cT classification | 0.001 | 0.002 | ||||
T1 | 1 | 1 | ||||
T2 | 0.650 | 0.807 | 0.320–2.034 | 0.454 | 0.697 | 0.270–1.797 |
T3 | 0.034 | 2.127 | 1.058–4.276 | 0.083 | 1.880 | 0.921–3.838 |
T4 | 0.002 | 5.201 | 1.843–14.676 | 0.009 | 4.107 | 1.420–11.875 |
Tx | 0.647 | 0.617 | 0.078–4.874 | 0.423 | 0.424 | 0.052–3.455 |
cN classification | 0.001 | 0.004 | ||||
N0 | 1 | 1 | ||||
N1 | 0.176 | 1.407 | 0.857–2.310 | 0.269 | 1.330 | 0.802–2.206 |
N2 | 0.003 | 2.285 | 1.318–3.962 | 0.010 | 2.116 | 1.195–3.748 |
N3 | < 0.001 | 4.859 | 2.003–11.789 | 0.002 | 4.134 | 1.688–10.127 |
Tumor histology | ||||||
Adenocarcinoma | 1 | 1 | ||||
SCC | 0.031 | 0.428 | 0.198–0.926 | 0.129 | 0.538 | 0.242–1.198 |
Histological grade | 0.410 | |||||
Well | 1 | |||||
Moderate | 0.380 | 1.902 | 0.453–7.989 | |||
Poor/Undifferentiated | 0.406 | 1.821 | 0.443–7.487 | |||
Unknown | 0.156 | 3.037 | 0.655–14.071 | |||
PORT | ||||||
Yes | 1 | |||||
No | 0.494 | 1.164 | 0.754–1.797 |
T, tumor; N, nodal; SCC, squamous cell carcinoma; PORT, postoperative radiotherapy.